Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Qualisys Strenghtens Executive Team with CMO Appointment

Qualisys

As part of its strategic growth agenda, Qualisys has established a new role within the executive leadership team and appoints Susanne Gerdin as Chief Marketing Officer, effective August 2025.

In this newly created role, Susanne will be responsible for leading the company’s global marketing strategy with a strong focus on brand development, market positioning, and customer engagement. As a member of the executive leadership team, she will align marketing initiatives with long-term business goals, support growth across key markets, and strengthen Qualisys’ global presence.

Susanne brings extensive experience from similar roles in international publicly listed companies. Most recently, she served as Marketing Director at LumenRadio, a fast-growing technology company, where she successfully led the marketing function and played a key role in the company’s stock market introduction. Earlier in her career, she held comparable positions in larger corporations, including Gunnebo AB.

“I’m truly excited to join the fantastic team at Qualisys and to contribute to the company’s continued development and strong market position,” says Susanne Gerdin.

“We are very pleased to welcome Susanne to Qualisys. Her proven ability to support growth through strategic marketing will be a valuable asset as we continue to scale,” says Ingemar Pettersson, CEO of Qualisys.

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore and Shanghai. Qualisys is certified according to ISO 9001:2015, the clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

Attachments
Qualisys Strenghtens Executive Team with CMO Appointment

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.